-
REVISITING THE DESIGN OF MANAGED ENTRY AGREEMENTS: A METHODOLOGICAL FRAMEWORK TO STREAMLINE THEIR ADOPTION
Aug 11, 2026, 17:16 PM -
VALUE FRAMEWORK FOR HEALTH TECHNOLOGY ASSESSMENT IN BRAZIL'S SUPPLEMENTARY HEALTH SYSTEM: IDENTIFYING THE KEY DRIVERS OF DECISION-MAKING (2021-2025)
Aug 11, 2026, 17:16 PM -
TRENDS AND DRIVERS FOR IN CANCER DRUGS FUND USE IN NON-SMALL CELL LUNG CANCER
Aug 11, 2026, 17:16 PM -
THE EVOLVING TREATMENT LANDSCAPE OF MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA: APPROVED THERAPIES AND AN EXPANDING LATE-STAGE PIPELINE
Aug 11, 2026, 17:16 PM -
TREATMENT PATTERNS AND DISEASE BURDEN IN CHINESE PATIENTS WITH WHO GRADE 2 ASTROCYTOMA AND OLIGODENDROGLIOMA: A CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:16 PM -
EARLY HEALTH ECONOMIC MODELING TO INFORM INTERVENTION AND TRIAL DESIGN OF COMPLEX PUBLIC HEALTH INTERVENTIONS: A CASE STUDY OF A COMMUNITY PHARMACIST LED HYPERTENSION INTERVENTION IN BANGLADESH AND PAKISTAN
Aug 11, 2026, 17:16 PM -
WHEN IS EXISTING PATIENT PREFERENCE INFORMATION FIT-FOR-REUSE? RECOMMENDATIONS FROM AN EDELPHI STUDY
Aug 11, 2026, 17:16 PM -
MACHINE LEARNING PREDICTION OF NON-INVASIVE VENTILATION FAILURE IN COPD: A TRIPOD-ALIGNED REAL-WORLD ANALYSIS
Aug 11, 2026, 17:16 PM -
REVIEW OF HEALTH TECHNOLOGY ASSESSMENTS FOR CELL AND GENE THERAPIES IN EUROPE
Aug 11, 2026, 17:16 PM -
CHARACTERISING PATIENTS WITH UNCONTROLLED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE US: A LATENT CLASS ANALYSIS (LCA) INCORPORATING CLINICAL, SOCIOECONOMIC AND DEMOGRAPHIC FACTORS
Aug 11, 2026, 17:16 PM -
DIRECT INTEGRATION OF MULTILEVEL NETWORK META-REGRESSION POSTERIOR DISTRIBUTIONS INTO COST-EFFECTIVENESS MODELS FOR DECISION-MAKING TAILORED TO LOCAL TARGET POPULATIONS
Aug 11, 2026, 17:16 PM -
ANNUAL ECONOMIC BURDEN OF HIDRADENITIS SUPPURATIVA IN GREECE: A CROSS-SECTIONAL PATIENT SURVEY
Aug 11, 2026, 17:16 PM -
A GLOBAL MODELING FRAMEWORK TO ESTIMATE THE LONG-TERM HEALTH AND ECONOMIC RETURNS OF CHILDHOOD OBESITY PREVENTION INITIATIVES ACROSS MULTIPLE COUNTRIES
Aug 11, 2026, 17:16 PM -
QUANTIFYING THE DISEASE BURDEN OF LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER (LA/MUC) USING A DISABILITY-ADJUSTED LIFE-YEARS (DALYS) ESTIMATION APPROACH: FINDINGS FROM A RETROSPECTIVE OBSERVATIONAL STUDY IN SWEDEN
Aug 11, 2026, 17:16 PM -
IMPORTANCE OF SCREENING EXAMINATIONS FOR SEXUALLY TRANSMITTED DISEASES AMONG INTERNATIONAL STUDENTS
Aug 11, 2026, 17:16 PM -
GLOBAL BURDEN AND TEMPORAL TRENDS OF KNEE OSTEOARTHRITIS: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY
Aug 11, 2026, 17:16 PM -
AI-SUPPORTED REIMBURSEMENT COMMUNICATION FOR PHARMACEUTICAL SALES TEAMS: A REAL-WORLD IMPLEMENTATION BY MARS AND HEALTHMIND
Aug 11, 2026, 17:16 PM -
WHEN IS IT SAFE FOR MEN AGED =65 YEARS WITH AN ABDOMINAL AORTIC ANEURYSM (AAA) TO EXIT FROM SCREENING? AN EVIDENCE MAP AND SUBSEQUENT RAPID REVIEW
Aug 11, 2026, 17:16 PM -
HOW MANY PATIENTS DOES A MICROSIMULATION NEED? CONVERGENCE IN PATIENT-LEVEL SIMULATION, AND THE DIMINISHING MARGINAL BENEFIT OF SIZE
Aug 11, 2026, 17:16 PM -
THE GLOBAL RIPPLE EFFECT OF US DRUG PRICING REFORMS: MANUFACTURER STRATEGIES, PAYER COUNTER-OFFENSIVES, AND HEOR TRANSFORMATION EX-US
Aug 11, 2026, 17:16 PM
